These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4046975)

  • 1. Extravasation of dactinomycin, vincristine, and cisplatin: studies in an animal model.
    Buchanan GR; Buchsbaum HJ; O'Banion K; Gojer B
    Med Pediatr Oncol; 1985; 13(6):375-80. PubMed ID: 4046975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous ulceration due to contrast extravasation. Experimental assessment of injury and potential antidotes.
    Elam EA; Dorr RT; Lagel KE; Pond GD
    Invest Radiol; 1991 Jan; 26(1):13-6. PubMed ID: 2022447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment methods for extravasations of chemotherapeutic agents: a comparative study.
    Loth TS; Eversmann WW
    J Hand Surg Am; 1986 May; 11(3):388-96. PubMed ID: 3711613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin ulceration potential of paclitaxel in a mouse skin model in vivo.
    Dorr RT; Snead K; Liddil JD
    Cancer; 1996 Jul; 78(1):152-6. PubMed ID: 8646711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
    Dorr RT; Alberts DS
    J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidote studies of vinorelbine-induced skin ulceration in the mouse.
    Dorr RT; Bool KL
    Cancer Chemother Pharmacol; 1995; 36(4):290-2. PubMed ID: 7628047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomes.
    Boman NL; Tron VA; Bally MB; Cullis PR
    Cancer Chemother Pharmacol; 1996; 37(4):351-5. PubMed ID: 8548881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal carboplatin and ifosfamide extravasation in the mouse.
    Marnocha RS; Hutson PR
    Cancer; 1992 Aug; 70(4):850-3. PubMed ID: 1643617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and management of extravasation of cytotoxic drugs.
    Bertelli G
    Drug Saf; 1995 Apr; 12(4):245-55. PubMed ID: 7646823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of extravasation in oncological care].
    Zatkóné Puskás G
    Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics.
    Soble MJ; Dorr RT; Plezia P; Breckenridge S
    Cancer Chemother Pharmacol; 1987; 20(1):33-6. PubMed ID: 3621451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidotes to vesicant chemotherapy extravasations.
    Dorr RT
    Blood Rev; 1990 Mar; 4(1):41-60. PubMed ID: 2182147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antidotes for extravasation injury produced by 6-hydroxymethylacylfulvene (MGI 114), a novel cytotoxic antitumor agent, in an intradermal toxicity model in rats.
    Marshall RF; Arthaud LE; MacDonald JR
    Cancer Chemother Pharmacol; 2000; 45(5):397-401. PubMed ID: 10803923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse.
    Dorr RT; Soble M; Alberts DS
    Cancer Chemother Pharmacol; 1988; 22(4):299-302. PubMed ID: 3168143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options in extravasation injury: an experimental study in rats.
    Yilmaz M; Demirdover C; Mola F
    Plast Reconstr Surg; 2002 Jun; 109(7):2418-23. PubMed ID: 12045569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse.
    Dorr RT; Alberts DS
    Cancer Treat Rep; 1983 May; 67(5):499-501. PubMed ID: 6850665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extravasation injury potential of CI-980, a novel synthetic mitotic inhibitor.
    MacDonald JR; Pegg DG
    Cancer Chemother Pharmacol; 1993; 32(5):365-7. PubMed ID: 8339386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse.
    Dorr RT; Alberts DS; Stone A
    Cancer Treat Rep; 1985 Apr; 69(4):431-7. PubMed ID: 3995512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin and perivascular toxicity induced experimentally by doxorubicin.
    Balsari A; Lombardo N; Ghione M
    J Chemother; 1989 Oct; 1(5):324-9. PubMed ID: 2585034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.
    Bertelli G; Gozza A; Forno GB; Vidili MG; Silvestro S; Venturini M; Del Mastro L; Garrone O; Rosso R; Dini D
    J Clin Oncol; 1995 Nov; 13(11):2851-5. PubMed ID: 7595748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.